D70-D77

Other disorders of blood and blood-forming organs and certain disorders involving the immune mechanism

The ICD-10 chapter section D70-D77 encompasses "Other disorders of blood and blood-forming organs and certain disorders involving the immune mechanism." This broad category serves as a crucial grouping for diverse hematologic and immunological pathologies not specifically classified in other sections of Chapter III (Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism). It provides a structured framework for coding conditions ranging from specific white blood cell disorders, such as agranulocytosis (D70) and functional defects of neutrophils (D71), to more general disturbances in white blood cell counts (D72). Furthermore, this section includes a variety of splenic diseases (D73), conditions affecting methaemoglobin (D74), and other unclassified disorders of blood and blood-forming organs (D75). It also covers certain diseases involving lymphoreticular tissue and reticulohistiocytic syndromes (D76), and a distinct category for other blood and blood-forming organ disorders that are manifestations of diseases classified elsewhere (D77). As a category code, D70-D77 is designed for classification and grouping purposes and is not intended for direct billing. Its primary function is to delineate the scope of disorders that fall under its umbrella, requiring clinicians and coders to refer to the more specific, billable sub-codes within this range for precise diagnostic reporting. The conditions captured here often involve complex etiologies, including genetic predispositions, autoimmune processes, infections, environmental exposures, or idiopathic origins. Accurate clinical documentation is paramount to correctly assigning codes within this range, as nuances in patient presentation, underlying pathology, and cellular involvement dictate the appropriate sub-code. This section ensures that various, sometimes rarer or less common, hematologic and immune system dysfunctions have a designated place within the ICD-10 system, facilitating comprehensive health record management, epidemiological studies, and healthcare resource allocation.

Clinical Symptoms

  • Unexplained fatigue
  • Recurrent infections
  • Easy bruising or bleeding
  • Swollen lymph nodes (lymphadenopathy)
  • Enlarged spleen (splenomegaly)
  • Persistent fever
  • Unintentional weight loss
  • Pale skin
  • Jaundice
  • Skin rashes or lesions
  • Joint pain

Common Causes

  • Genetic predispositions
  • Autoimmune disorders
  • Viral or bacterial infections
  • Exposure to certain drugs or toxins
  • Bone marrow dysfunction or failure
  • Lymphoproliferative disorders
  • Hypersplenism
  • Metabolic disorders affecting blood components
  • Idiopathic (unknown) etiologies

Documentation & Coding Tips

Always specify the exact type and etiology of the blood or immune disorder when known. Avoid vague terms. If secondary, clearly link it to the underlying primary condition.

Example: POOR DOCUMENTATION: "Patient with neutropenia, likely due to medication." GOOD DOCUMENTATION: "Patient presents with severe drug-induced neutropenia (ANC 0.5 K/uL) secondary to recent chemotherapy for metastatic colon cancer. Patient is currently afebrile but reports generalized fatigue and mucositis. Chemotherapy regimen paused, initiating G-CSF support. This is an acute, severe episode of neutropenia directly related to antineoplastic treatment."

Billing Focus: Specifying 'drug-induced' and 'severe' allows for selection of the most specific ICD-10 code (e.g., D70.1 for agranulocytosis due to antineoplastic drug). Linking to chemotherapy and colon cancer provides medical necessity for all services.

Document the chronicity (acute vs. chronic) and severity (mild, moderate, severe) of the condition, along with any current manifestations or complications.

Example: POOR DOCUMENTATION: "Patient with immune deficiency." GOOD DOCUMENTATION: "Patient with chronic primary common variable immunodeficiency (CVID), diagnosed 5 years ago, presenting with acute onset of recurrent sinusitis (now confirmed bacterial, requiring antibiotics) and persistent diarrhea (likely giardiasis). Patient is also experiencing mild fatigue and arthralgias. Immunoglobulin G levels remain critically low despite scheduled IVIG infusions every 4 weeks."

Billing Focus: "Chronic primary CVID" ensures the correct and most specific ICD-10 code (e.g., D83.0 for CVID predominantly with abnormalities of B-cell numbers or function). Documenting specific acute complications (bacterial sinusitis, giardiasis) allows for additional, justified coding and medical necessity for treatment.

Describe associated symptoms, findings, and the impact on the patient's daily activities or functional status.

Example: POOR DOCUMENTATION: "Patient with low platelets." GOOD DOCUMENTATION: "Patient diagnosed with immune thrombocytopenia (ITP), platelets 25,000/uL, experiencing recurrent epistaxis and new onset of petechiae on bilateral lower extremities. Reports significant fear of bleeding preventing engagement in normal daily activities. Requiring oral corticosteroid tapering and close hematology follow-up."

Billing Focus: Documenting 'immune thrombocytopenia' and specific symptoms (epistaxis, petechiae) supports the ICD-10 code (e.g., D69.3 for ITP). The severity of platelets count and active bleeding justifies medical intervention and resource utilization.

Clearly document the presence or absence of splenomegaly and any related functional impact, as it can be an important clinical finding for many hematologic disorders.

Example: POOR DOCUMENTATION: "Spleen enlarged." GOOD DOCUMENTATION: "Patient with established diagnosis of myelofibrosis, follow-up visit. Physical exam reveals palpable splenomegaly, extending 5 cm below the left costal margin, which the patient reports is causing significant early satiety and left upper quadrant discomfort, impacting oral intake. Current laboratory findings show progressive anemia and worsening thrombocytopenia. Discussed potential for JAK inhibitor initiation due to symptomatic splenomegaly and progressive cytopenias."

Billing Focus: Documenting 'myelofibrosis' (an HCC condition) along with 'palpable splenomegaly' and its specific size/location provides robust justification for evaluation and management. The reported symptoms (early satiety, discomfort) link directly to the enlarged spleen, validating interventions.

Relevant CPT Codes

Related Diagnoses

Hierarchy